bpc-157 противопоказания 5mg SP Labotatory Benefits of BPC-157 - Mousai
Description
This range depends on: Severity of the injury Age and metabolic health Rehabilitation and movement patterns What Drives These Healing Effects
- intrinsic factor deficiency - D51.0 - factor (congenital) - D51.0 - combined (spinal cord) (subacute) - E53.8 - with anemia (pernicious) - D51.0 - Disease, diseased - See Also: Syndrome
5 mg vial + 2 mL BAC water: Concentration = 2,500 mcg/mL 250 mcg dose = 10 units (0.1 mL) on a 100-unit insulin syringe 500 mcg dose = 20 units (0.2 mL) on a 100-unit insulin syringe Doses per vial: 20 doses at 250 mcg, or 10 doses at 500 mcg Supplies Needed (8-Week Cycle at 250 mcg/day) 3 vials BPC-157 (5 mg each) provides 60 doses, covers 56 days with margin 3 vials bacteriostatic water (30 mL each) 60 insulin syringes (2931 gauge, 100-unit) Alcohol prep pads Administration Injection Technique BPC-157 goes subcutaneous (SubQ)
By accessing this product, you consent to comply with these terms and conditions
Target-based mechanisms of action More than 5,000 proteins are targeted by mAbs covered in filed patents
Severity grade 1-5 was used (1 = minimal
